Rivaroxaban
Showing 1 - 9 of 9
Direct Oral AntiCoagulants and Ticagrelor Study II
Not yet recruiting
- Novel Oral Anticoagulants
- +11 more
- Detection of genotype and RNA profile in platelet and white blood cell
- +2 more
-
Hefei, Anhui, China
- +5 more
Mar 1, 2023
Kawasaki Disease, Coronary Aneurysm, Rivaroxaban Trial (Rivaroxaban Oral Tablet or Suspension [Xarelto], Aspirin or Clopidogrel,
Not yet recruiting
- Kawasaki Disease
- +4 more
- Rivaroxaban Oral Tablet or Suspension [Xarelto]
- +2 more
- (no location specified)
Dec 6, 2022
Cancer, Rivaroxaban, Venous Thromboembolism Trial in Santo André (Rivaroxaban, Enoxaparin)
Recruiting
- Cancer
- +3 more
-
Santo André, São Paulo, BrazilScience Valley Research Institute
Aug 3, 2021
Rivaroxaban Trial (clopidogrel combined with rivaroxaban arm)
Not yet recruiting
- Rivaroxaban
- clopidogrel combined with rivaroxaban arm
- (no location specified)
Mar 16, 2021
Pharmacodynamics of Direct Oral Anticoagulants
Unknown status
- Novel Oral Anticoagulants
- +8 more
- detection of genotype
-
Hefei, Anhui, China
- +16 more
Dec 19, 2020
Rivaroxaban in Elderly NVAF or Without Renal Impairment
Unknown status
- Atrial Fibrillation
- +3 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Oct 19, 2020
Atrial Fibrillation, Left Atrial Appendage Thrombosis, Rivaroxaban Trial (Rivaroxaban, Warfarin)
Unknown status
- Atrial Fibrillation
- +2 more
- (no location specified)
Mar 18, 2019
Rivaroxaban, Cancer-associated Thrombosis, Recurrence Trial in Seongnam (Rivaroxaban)
Completed
- Rivaroxaban
- +3 more
-
Seongnam, Korea, Republic ofSeoul National University Bundang Hospital
Jan 6, 2017